Efficacy of Paracetamol in treatment of patent dactus arteriosus in neonates
Phase 3
- Conditions
- Patent ductus arteriosus in neonate.Patent Ductus Arteriosus
- Registration Number
- IRCT20170910036112N2
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All neonates with post natal age more than 3 days with hemodynamically significant PDA;
Acceptance of inform consent by parents.
Exclusion Criteria
All congenital heart diseases other than PDA
Contraindication of using ibuprofen or acetaminophen
Persistence fetal circulation (PFC)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Closure of PDA in neonate. Timepoint: 72 hours after birth and after 3 days of therapy initiation (therapy completion). Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method _. Timepoint: _. Method of measurement: _.